← Leaderboards
Barbara Driver
Westat, Inc.
$270,069,085
Attributed
$270,069,085
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.4M · FY2012–25$50M$37.5M$25M$12.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$294,665,780 · 7
By mechanism
N01$250,187,083 · 4
UM2$44,478,697 · 3
Top collaborators
- Daniel Hunter Reirden4 shared
Most similar at Westat, Inc.
Same institution · by research overlap
- Parbara Driver$356,984
- Carol Nesel$29,450,031
- Driver Barbara$892,210
- Barbara Drivers$2,800,000
Others in their field
Top investigators on “National Institute Of Child Health And Human Development”
- George R Seage · Abt Associates, Inc.$190,884,554
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$169,177,396
- Abhik Das · Research Triangle Institute$165,925,750
- Daniel R Kuritzkes · Brigham And Women'S Hospital$101,405,551
- Rebecca Gersnoviez Clifton · George Washington University$88,542,522
Research focus
National Institute Of Child Health And Human DevelopmentSiteProtocols DocumentationClinical TrialsHiv InfectionsResearch PersonnelAdolescentPreventionFundingMonitorEpidemiologyInternationalConduct Clinical TrialsChildChildhoodNational Institute Of Allergy And Infectious DiseaseCollaborationsUnited States National Institutes Of HealthAids Clinical Trial GroupPatient PopulationServicesSpecimenInfantPregnant Women
Grant awards (65)
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES$4,748,065
N01 · FY2025 · HD · contact PI
Operations and Collaborations Center - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)$4,665,913
UM2 · FY2025 · HD · contact PI
SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS$2,802,733
N01 · FY2025 · HD · contact PI
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS$1,999,984
N01 · FY2025 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK$1,360,368
N01 · FY2025 · HD · contact PI
IMPAACT 2041: PHASE I/II STUDY OF THE PHARMACOKINETICS AND SAFETY OF GLECAPREVIR/PIBRENTASVIR INITIATED IN PREGNANCY IN PEOPLE WITH HEPATITIS C WITH AND WITHOUT HIV$1,125,154
N01 · FY2025 · HD · contact PI
HIV IMPAACT RELATED STUDIES$19,948
N01 · FY2025 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)$7,583,126
UM2 · FY2024 · HD · contact PI
Operations and Collaborations Center - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)$6,775,609
UM2 · FY2024 · HD · contact PI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES$5,474,227
N01 · FY2024 · HD · contact PI
SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS$3,324,580
N01 · FY2024 · HD · contact PI
OPEN-LABEL PHASE I STUDY OF THE SAFETY AND PHARMACOKINETICS OF NEUTRALIZING MONOCLONAL ANTIBODIES IN INFANTS EXPOSED TO HIV-I$2,505,456
N01 · FY2024 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK$2,046,878
N01 · FY2024 · HD · contact PI
P1115 - VERY EARLY INTENSIVE TREATMENT OF HIV-INFECTED INFANTS TO ACHIEVE HIV REMISSION: A PHASE I/II PROOF OF CONCEPT STUDY$2,044,287
N01 · FY2024 · HD · contact PI
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS$1,972,938
N01 · FY2024 · HD · contact PI
HIV AND OTHER IMPAACT RELATED INFECTIOUS DISEASE STUDIES$247,497
N01 · FY2024 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)$7,456,617
UM2 · FY2023 · HD · contact PI
Operations and Collaborations Center - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)$4,248,110
UM2 · FY2023 · HD · contact PI
SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS$3,544,291
N01 · FY2023 · HD · contact PI
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS$2,725,226
N01 · FY2023 · HD · contact PI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES$2,420,364
N01 · FY2023 · HD · contact PI
TUBERCULOSIS PREVENTION IN CHILDREN TWO TO LESS THAN 13 YEARS OF AGE WITH AND WITHOUT HIV$2,220,803
N01 · FY2023 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center$2,167,421
UM2 · FY2023 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK$1,461,465
N01 · FY2023 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS (PATC3H) (UG3/UH3) PROGRAM$783,814
N01 · FY2023 · HD · contact PI
COMPLETION OF DATA HARMONIZATION IN PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS (PATC3H) PROGRAM$473,845
N01 · FY2023 · HD · contact PI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)$7,389,531
UM2 · FY2022 · HD · contact PI
Operations and Collaborations Center - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)$4,192,370
UM2 · FY2022 · HD · contact PI
SUPPORT SERVICES FOR THE HIV AIDS CLINICAL TRIALS NETWORKS$4,189,120
N01 · FY2022 · HD · contact PI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES$2,312,964
N01 · FY2022 · HD · contact PI
SECONDARY DATA ANALYSES AND INVESTIGATION OF RESEARCH CONCEPT PROPOSALS FROM THE PROSPECTIVE COHORT OF HIV AND ZIKA IN INFANTS AND PREGNANCY STUDY (HIV-ZIP)$1,466,424
N01 · FY2022 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS (PATC3H) (UG3/UH3) PROGRAM$656,490
N01 · FY2022 · HD · contact PI
A5418 STUDY OF TECOVIRIMAT FOR HUMAN MONKEYPOX VIRUS (STOMP)$605,168
N01 · FY2022 · HD · contact PI
STUDY CLOSEOUT FOR THE INTERNATIONAL COHORT STUDY OF CHILDREN BORN TO WOMEN INFECTED WITH ZIKA VIRUS DURING PREGNANCY (ZIP 2.0)$499,998
N01 · FY2022 · HD · contact PI
PHASE I STUDY OF PHARMACOKINETICS, SAFETY AND ACCEPTABILITY OF A SINGLE DOSE OF PRETOMANID ADDED TO AN OPTIMIZED BACKGROUND REGIMEN IN CHILDREN WITH RIFAMPICIN RESISTANT TUBERCULOSIS IMPAACT 2034$299,389
N01 · FY2022 · HD · contact PI
SUPPORT SERVICES FOR THE HIV AIDS CLINICAL TRIALS NETWORKS$3,812,115
N01 · FY2021 · HD · contact PI
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS$2,486,704
N01 · FY2021 · HD · contact PI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES$2,410,479
N01 · FY2021 · HD · contact PI
ZIP 2.0 STUDY CHILD COHORT WITH INTERIM ANALYSIS OF AGE 30 MONTHS DATA$2,330,566
N01 · FY2021 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS (PATC3H) (UG3/UH3) PROGRAM$679,596
N01 · FY2021 · HD · contact PI
SUPPORT SERVICES FOR THE HIV AIDS CLINICAL TRIALS NETWORKS$3,818,588
N01 · FY2020 · HD · contact PI
HIV IMPAACT RELATED STUDIES$1,746,450
N01 · FY2020 · HD · contact PI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES$1,650,681
N01 · FY2020 · HD · contact PI
IMPAACT INVESTIGATIONS FOR FUTURE STUDIES$1,000,503
N01 · FY2020 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS (PATC3H) (UG3/UH3) PROGRAM$505,763
N01 · FY2020 · HD · contact PI
HIV AND OTHER IMPAACT RELATED INFECTIOUS DISEASE STUDIES$12,791,430
N01 · FY2019 · HD · contact PI
HIV IMPAACT RELATED STUDIES$5,258,594
N01 · FY2019 · HD · contact PI
SUPPORT SERVICES FOR THE HIV AIDS CLINICAL TRIALS NETWORKS$3,507,902
N01 · FY2019 · HD · contact PI
FOLLOW-UP THROUGH 12 MONTHS OF AGE ON ALL INFANTS ENROLLED IN THE PROSPECTIVE COHORT STUDY OF HIV AND ZIKA IN INFANTS AND PREGNANCY (HIV ZIP) FEASIBILITY STUDY$2,111,525
N01 · FY2019 · HD · contact PI
RANDOMIZED TRIAL TO EVALUATE THE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT POTENT REGIMENS IN HIV INFECTED WOMEN$699,969
N01 · FY2019 · HD · contact PI
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS (PATC3H) (UG3/UH3) PROGRAM$416,168
N01 · FY2019 · HD · contact PI
HIV IMPAACT RELATED STUDIES$19,146,486
N01 · FY2018 · HD · contact PI
INTERNATIONAL PROSPECTIVE OBSERVATIONAL COHORT STUDY OF ZIKA IN INFANTS AND PREGNANCY (ZIP STUDY)$4,481,188
N01 · FY2018 · HD · contact PI
SUPPORT SERVICES FOR THE HIV AIDS CLINICAL TRIALS NETWORKS$3,640,190
N01 · FY2018 · HD · contact PI
FEASIBILITY STUDY OF A PROSPECTIVE COHORT OF HIV & ZIKA IN INFANTS AND PREGNANCY (HIV-ZIP)$3,595,918
N01 · FY2018 · HD · contact PI
INTERNATIONAL COHORT STUDY OF CHILDREN BORN TO WOMEN INFECTED WITH ZIKA VIRUS DURING PREGNANCY$2,882,462
N01 · FY2018 · HD · contact PI
RANDOMIZED TRIAL TO EVALUATE THE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT POTENT REGIMENS IN HIV INFECTED WOMEN$1,779,078
N01 · FY2018 · HD · contact PI
MURINE REPRODUCTIVE TOXICITY STUDIES TO EVALUATE POTENTIAL NEURAL TUBE DEFECTS ASSOCIATED WITH DOLUTEGRAVIR$493,443
N01 · FY2018 · HD · contact PI
EVALUATION OF THE HIV-1 RESERVOIR IN THE CENTRAL NERVOUS SYSTEM OF PERINATALLY INFECTED YOUTH & YOUNG ADULTS W/COGNITIVE IMPAIRMENT$258,237
N01 · FY2018 · HD · contact PI
NICHD INTERNATIONAL & DOMESTIC PEDIATRIC & MATERNAL HIV STUDIES DATA COORDINATING CENTER$131,805
N01 · FY2018 · HD · contact PI
NICHD INTERNATIONAL & DOMESTIC PEDIATRIC & MATERNAL HIV STUDIES DATA COORDINATING CENTER$29,139,313
N01 · FY2017 · HD · contact PI
NICHD INTERNATIONAL & DOMESTIC PEDIATRIC & MATERNAL HIV STUDIES DATA COORDINATING CENTER$33,197,048
N01 · FY2016 · HD · contact PI
NICHD INTERNATIONAL & DOMESTIC PEDIATRIC & MATERNAL HIV STUDIES DATA COORDINATING CENTER$33,256,095
N01 · FY2015 · HD · contact PI
NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS$9,967,733
N01 · FY2013 · AI · contact PI
NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS$9,659,578
N01 · FY2012 · AI · contact PI